Evidence map›Paper›PMID 27432243›Full record

ArticleAnnals of intensive care2016

Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis.

Franziska C Trudzinski, Peter Minko, Daniel Rapp, Sebastian Fähndrich, Hendrik Haake, Myriam Haab, Rainer M Bohle, Monika Flaig, Franziska Kaestner, Robert Bals and 7 more

Open access · goldAbstract read
In one paragraph

Article in Annals of intensive care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Assessing Venous Thrombotic Risks in Extracorporeal Membrane Oxygenation-Supported Patients: A Systematic Review and Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Franziska C TrudzinskiDepartment of Internal Medicine V - Pneumology and Critical Care Medicine, University Hospital of Saarland, Homburg, Germany.
Peter MinkoDepartment of Diagnostic and Interventional Radiology, University Hospital of Saarland, Homburg, Germany.
Daniel RappInstitutes for Medical Biometry, Epidemiology and Medical Informatics, Saarland University, Homburg, Germany.
Sebastian FähndrichDepartment of Internal Medicine V - Pneumology and Critical Care Medicine, University Hospital of Saarland, Homburg, Germany.
Hendrik HaakeDepartment of Cardiology, Kliniken Maria-Hilf GmbH, Mönchengladbach, Germany.
Myriam HaabDepartment of Pathology, University Hospital of Saarland, Homburg, Germany.
Rainer M BohleDepartment of Pathology, University Hospital of Saarland, Homburg, Germany.
Monika FlaigDepartment of Internal Medicine V - Pneumology and Critical Care Medicine, University Hospital of Saarland, Homburg, Germany.
Franziska KaestnerDepartment of Internal Medicine V - Pneumology and Critical Care Medicine, University Hospital of Saarland, Homburg, Germany.
Robert BalsDepartment of Internal Medicine V - Pneumology and Critical Care Medicine, University Hospital of Saarland, Homburg, Germany.
Heinrike WilkensDepartment of Internal Medicine V - Pneumology and Critical Care Medicine, University Hospital of Saarland, Homburg, Germany.
Ralf M MuellenbachDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital of Würzburg, Würzburg, Germany.
Andreas LinkDepartment of Internal Medicine III - Cardiology, and Critical Care Medicine, University Hospital of Saarland, Homburg, Germany.
Heinrich V GroesdonkDepartment of Anaesthesiology, Critical Care Medicine and Pain Therapy, University Hospital of Saarland, Homburg, Germany.
Christian LenschDepartment of Internal Medicine V - Pneumology and Critical Care Medicine, University Hospital of Saarland, Homburg, Germany.
Frank LangerDepartment of Thoracic and Cardiovascular Surgery, University Hospital of Saarland, Homburg, Germany.
Philipp M LepperDepartment of Internal Medicine V - Pneumology and Critical Care Medicine, University Hospital of Saarland, Homburg, Germany. philipp.lepper@uks.eu.
Saarland University · DEKliniken Maria Hilf · DEUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEven though bleeding and thromboembolic events are major complications of extracorporeal membrane oxygenation (ECMO), data on the incidence of venous thrombosis (VT) and thromboembolism (VTE) under ECMO are scarce. This study analyzes the incidence and predictors of VTE in patients treated with ECMO due to respiratory failure.

methodsRetrospective analysis of patients treated on ECMO in our center from 04/2010 to 11/2015. Patients with thromboembolic events prior to admission were excluded. Diagnosis was made by imaging in survivors and postmortem examination in deceased patients.

resultsOut of 102 screened cases, 42 survivors and 21 autopsy cases [mean age 46.0 ± 14.4 years; 37 (58.7 %) males] fulfilling the above-mentioned criteria were included. Thirty-four patients (54.0 %) underwent ECMO therapy due to ARDS, and 29 patients (46.0 %) with chronic organ failure were bridged to lung transplantation. Despite systemic anticoagulation at a mean PTT of 50.6 ± 12.8 s, [VT/VTE 47.0 ± 12.3 s and no VT/VTE 53.63 ± 12.51 s (p = 0.037)], VT and/or VTE was observed in 29 cases (46.1 %). The rate of V. cava thrombosis was 15/29 (51.7 %). Diagnosis of pulmonary embolism prevailed in deceased patients [5/21 (23.8 %) vs. 2/42 (4.8 %) (p = 0.036)]. In a multivariable analysis, only aPTT and time on ECMO predicted VT/VTE. There was no difference in the incidence of clinically diagnosed VT in ECMO survivors and autopsy findings.

conclusionsVenous thrombosis and thromboembolism following ECMO therapy are frequent. Quality of anticoagulation and ECMO runtime predicted thromboembolic events.

Identifiers

PMID27432243
PMCPMC4949188
OpenAlexW2503037892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.